Loading…
Chinese equipment maker based in Wuxi; exact product scope (imaging/inspection equipment) not independently confirmed.
Chinese equipment maker based in Wuxi; exact product scope (imaging/inspection equipment) not independently confirmed.
Moat: none
Headquarters: Wuxi, Jiangsu, China · Employees: 1,302
Size Wuxi Unicomp Technology (688531.SS) is a China Health Care company (Medical Specialties) with a market value of $1.80B, the 1395th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥76.86 on 6 Nov 2026.
Performance Over six months the shares fell 36.3%, against -4.2% for the median peer and -16.4% for the China market (cap-weighted) — 3rd lowest of 21 in its peer set.
Growth Revenue grew 53.0% over the last twelve months (peer median +9.6%); the operating margin is 11.8% (peer median 12.4%).
Valuation It trades at 40.7× forward earnings against a peer median of 26.6× (7th most expensive of 19).
Capital Return on invested capital runs 11.3 points below its cost of capital (16.4% WACC).
Next results Next results expected around 3 May 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.48B | CN¥1.07B | CN¥736M | CN¥585M | CN¥485M |
| Revenue growth | — | +46% | +26% | +21% | — |
| Gross profit | CN¥678M | CN¥448M | CN¥307M | CN¥214M | n/a |
| EBITDA | n/a | CN¥163M | CN¥102M | CN¥62.0M | n/a |
| Net income | CN¥248M | CN¥176M | CN¥143M | CN¥114M | CN¥71.7M |
| Free cash flow | -CN¥167M | -CN¥102M | -CN¥151M | -CN¥90.8M | n/a |
| Capital expenditure | CN¥396M | CN¥334M | CN¥225M | CN¥121M | CN¥0 |
| Total debt | CN¥370M | CN¥275M | CN¥119M | CN¥118M | CN¥0 |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Wuxi Unicomp Technology 688531.SS | $1.80B | -36% | +53% | 12% | 40.7× | n/a |
| COMET COTN.SW | $2.84B | -9% | -3% | 6% | 34.0× | n/a |
| Nordson NDSN | $17.3B | +10% | +7% | 27% | 24.5× | 15.4% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 688531.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -35.6% | -0.5% | 3rd lowest of 21 |
| 6-month return | -36.3% | -4.2% | 3rd lowest of 21 |
| Distance from 52-week high | -64.2% | -28.9% | 2nd lowest of 21 |
| Revenue growth (TTM) | +53.0% | +9.6% | 3rd highest of 21 |
| Operating margin | 11.8% | 12.4% | 11th highest of 21 |
| Forward P/E | 40.7× | 26.6× | 7th most expensive of 19 |
| ROIC minus cost of capital | -11.3 pp | +1.1 pp | 3rd lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Wuxi Unicomp Technology 688531.SS | China | $1.80B | -36% | +53% | 12% | 40.7× | n/a | n/a |
| Medartis MED.SW | Switzerland | $1.83B | +47% | +30% | 2% | 74.2× | n/a | n/a |
| Fukuda Denshi 6960.T | Japan | $1.75B | -5% | 0% | 19% | 14.6× | -3.2% | -1.0% |
| Embla Medical hf EMBLA.CO | Denmark | $1.75B | +3% | +6% | 14% | 17.9× | -1.8% | +8.3% |
| Inner Mongolia Furui Medical Science 300049.SZ | China | $1.85B | -5% | +11% | 25% | 53.2× | 6.6% | +14.6% |
| LeMaitre Vascular LMAT | United States | $1.85B | -25% | +12% | 29% | 26.2× | 2.9% | +14.0% |
| Inspire Medical Systems INSP | United States | $1.85B | +45% | 0% | 2% | 45.4× | 30.9% | +51.2% |
| Angelalign Technology 6699.HK | Hong Kong | $1.74B | -7% | +84% | 9% | 52.1× | 18.1% | +25.8% |
| Poly Medicure POLYMED.NS | India | $1.73B | -4% | +18% | 17% | 40.6× | n/a | n/a |
| Kestra Medical Technologies KMTS | United States | $1.72B | +37% | +61% | -134% | n/a | n/a | n/a |
| Cofoe Medical Technology 301087.SZ | China | $1.71B | -5% | +33% | 10% | 26.9× | 12.5% | +7.4% |
| DENTSPLY SIRONA XRAY | United States | $1.89B | -14% | -1% | 5% | 7.3× | 10.2% | +1.9% |
| Butterfly Network BFLY | United States | $1.70B | +53% | +39% | -36% | n/a | n/a | n/a |
| Draegerwerk AG & Co. KGaA DRW8.DE | Germany | $1.89B | +17% | +5% | 7% | 9.4× | -12.6% | +0.4% |
| ChemoMetec A/S CHEMM.CO | Denmark | $1.69B | +124% | +3% | 49% | 52.0× | 17.9% | +12.7% |
| SKAN SKAN.SW | Switzerland | $1.92B | +49% | +9% | 11% | 49.8× | 13.8% | +11.7% |
| Rigaku 268A.T | Japan | $1.66B | -57% | +5% | 15% | 20.4× | 18.8% | +14.5% |
| Veracyte VCYT | United States | $1.94B | -40% | +17% | 17% | 14.9× | 15.1% | +34.5% |
| Mehow Innovative 301363.SZ | China | $1.95B | -14% | +10% | 21% | 38.8× | 18.9% | +12.9% |
| Shandong Weigao Group Medical Polymer 1066.HK | Hong Kong | $1.96B | -4% | +7% | 14% | 8.8× | -11.8% | +2.1% |
| JEOL 6951.T | Japan | $1.98B | -3% | -18% | 11% | 14.2× | 21.3% | +10.2% |